Copy to clipboard 
Osteotec opened new offices in Ireland and Sweden to further support its continued business growth.
The expansion positions Osteotec to meet increasing customer demand and brings the company closer to local clients, partners and stakeholders in Ireland, the Nordics and across Europe.
Located in Blanchardstown Corporate Park in Dublin, Osteotec’s new division allows closer alignment with the innovation-led medtech ecosystem in Ireland.
The simultaneous launch of a base of operations in Malmö will see the business enter a Nordic medical device market with an offering of niche orthopedic and implantable device ranges.
Osteotec Group General Manager Anthony McClellan said, “These new sites represent the continuation of Osteotec’s long-standing commitment to our clients and partners within key markets and set the stage for the next critical phase in Osteotec’s development. This investment is part of our vision to continually enhance and upgrade our service for our customers, and we’re thrilled to be able to bring onboard talented and experienced new colleagues who are locally based. These key regions present us with an exceptional opportunity to build on existing business and form meaningful new connections that enhance patient and surgical outcomes.”
Osteotec launched a new website, logo and rebrand as part of their 30th anniversary celebrations earlier this year.
The expansion follows the announcement of Osteotec’s exclusive distribution partnership with Enovis UK & Ireland and Mathys International in November 2022. Further recent announcements have included new UK distribution partnerships with G21, Beznoska and Exabone, complementing Osteotec’s existing and long-standing relationships in the UK, including TriMed.
“We are excited by the prospects that lie ahead in these key regions, which present exceptional opportunities for Osteotec and our global manufacturing partners,” said Anthony McClellan. “We look forward to working with new colleagues and partners to deliver innovative products that stand the test of time.”
Source: Osteotec
Osteotec opened new offices in Ireland and Sweden to further support its continued business growth.
The expansion positions Osteotec to meet increasing customer demand and brings the company closer to local clients, partners and stakeholders in Ireland, the Nordics and across Europe.
Located in Blanchardstown Corporate Park in Dublin,...
Osteotec opened new offices in Ireland and Sweden to further support its continued business growth.
The expansion positions Osteotec to meet increasing customer demand and brings the company closer to local clients, partners and stakeholders in Ireland, the Nordics and across Europe.
Located in Blanchardstown Corporate Park in Dublin, Osteotec’s new division allows closer alignment with the innovation-led medtech ecosystem in Ireland.
The simultaneous launch of a base of operations in Malmö will see the business enter a Nordic medical device market with an offering of niche orthopedic and implantable device ranges.
Osteotec Group General Manager Anthony McClellan said, “These new sites represent the continuation of Osteotec’s long-standing commitment to our clients and partners within key markets and set the stage for the next critical phase in Osteotec’s development. This investment is part of our vision to continually enhance and upgrade our service for our customers, and we’re thrilled to be able to bring onboard talented and experienced new colleagues who are locally based. These key regions present us with an exceptional opportunity to build on existing business and form meaningful new connections that enhance patient and surgical outcomes.”
Osteotec launched a new website, logo and rebrand as part of their 30th anniversary celebrations earlier this year.
The expansion follows the announcement of Osteotec’s exclusive distribution partnership with Enovis UK & Ireland and Mathys International in November 2022. Further recent announcements have included new UK distribution partnerships with G21, Beznoska and Exabone, complementing Osteotec’s existing and long-standing relationships in the UK, including TriMed.
“We are excited by the prospects that lie ahead in these key regions, which present exceptional opportunities for Osteotec and our global manufacturing partners,” said Anthony McClellan. “We look forward to working with new colleagues and partners to deliver innovative products that stand the test of time.”
Source: Osteotec
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
